Lertora, J.J.L. , Mark, A.L., Johannsen, U.J., et al.: Selective beta-1 receptor blockade with oral practolol in man. J. Clin. Invest.56: 719, 1975.
2.
Barrett, A.M. , Carter, J.: Comparative chronotropic activity of β-adrenoceptive antagonist. Br. J. Pharmacol., 40: 373, 1970.
3.
Robinson, B.F. : The mode of action of beta-antagonists in angina pectoris. Postgrad. Med. J., 47(Suppl. 2): 41, 1971.
4.
Prichard, B.N.C. : β-receptor antagonists in angina pectoris. Ann. Clin. Res., 3: 344, 1971.
5.
Imhof, R.P.: Characterization of beta blockers as antihypertensive agents in the light of human pharmacology studies, in Beta-Blockers—Present Status and Future Prospects. Edited by W. Schweizer.Bern, Hans Huber, 1974, p. 40.
6.
Frishman, W. , Kostis, J., Strom, J., et al.: Appraisal and reappraisal of cardiac therapy. Am. Heart J.98: 526, 1979.
7.
Thadani, U., Davidson, C., Chir, B., et al.: Comparison of immediate effects of five β-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. N. Engl. J. Med., 300: 750, 1979.
8.
Beumer, H.M. , Tierlinck, C., Wiseman, R.A.: Comparative investigation of the respiratory and cardiovascular effect of mepindolol, propranolol and pindolol in asthmatic patients. Int. J. Clin. Pharmacol., 61: 249, 1978.
9.
Frishman, W. , Davis, R., Strom, J., et al.: Clinical pharmacology of the new beta-adrenergic blocking drugs. V. Pindolol (LB-36) therapy for supraventricular arrhythmia. A viable alternative to propranolol in patients with bronchospasm . Am. Heart J., 98: 393, 1979.
10.
Giudicelli, M.F., Lhoste, F., Bossier, J.R.: β-adrenergic blockade and atrio-ventricular conduction impairment. Eur. J. Pharmacol., 31: 216, 1975.